Metabolic Category
Liraglutide
THE DAILY
Saxenda, Victoza
Liraglutide is a GLP-1 receptor agonist that works similarly to Semaglutide but requires daily injections instead of weekly. It helps control appetite, slows digestion, and improves blood sugar regulation. Originally developed for diabetes (Victoza), a higher dose version (Saxenda) was approved specifically for weight management. It's a proven option for those who prefer more frequent, smaller doses.
Liraglutide Evidence Snapshot
How these guides are reviewed- Regulatory status
- FDA-approved uses exist
- Dosing guidance
- Reviewed by our clinical team
- Linked evidence
- 4 research sources
- Content updated
- Jul 15, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
Quick Answers About Liraglutide
Is Liraglutide FDA approved?
This profile records Liraglutide as FDA approved.
More context
Approval can be specific to a formulation, indication, and prescribing context, so review the regulatory and source details on this page.
What dose does The Peptide App Clinical Team recommend for Liraglutide?
Dose: 0.6mg to 3mg daily (gradual increase).
More context
Schedule: daily. Cycle: Continuous use with medical supervision. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
What research supports this Liraglutide guide?
This guide links to 4 curated or current research sources.
More context
Inspect the research section and the citations beneath the research answers for their supporting sources.
Review the Liraglutide research sourcesWhat are the side effects of Liraglutide?
Reported side effects of Liraglutide include Nausea, Diarrhea, Constipation, and Injection site reactions.
More context
They are reported or occasional reactions, not a prediction of what any one person will experience.
Is Liraglutide safe?
Liraglutide has an editorial safety grade of A (FDA Approved).
More context
FDA-approved with extensive clinical trial data. Well-established safety profile. Safety depends on dose, sourcing, health history and medical supervision, so this page does not call it safe for personal use.
What is Liraglutide and what drug class does it belong to?
Liraglutide is classed as a glucagon-like peptide-1 receptor agonist (GLP-1 RA). It is one of the GLP-1 RAs included in a scoping review of anti-obesity medications. According to the source describing it, liraglutide targets appetite regulation, body weight, glycemic control and insulin sensitivity.
- Comparative Efficacy and Safety of Liraglutide Versus Metformin in Women With Polyendocrine Metabolic Ovarian Syndrome (PMOS): A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Novel cutaneous adverse effects of the increasingly prevalent glucagon-like peptide 1 agonists.
- Recent Studies on the Effectiveness and Safety of Anti-Obesity Medications: A Scoping Review.
GLP-1 molecular design
Liraglutide comes from Novo Nordisk's program to modify the naturally occurring peptide GLP-1. Its structure includes an arginine substitution at position 34 and a C16 fatty-acid group attached at lysine 26 through a glutamate linker. This lipid attachment is a chemical feature of the peptide itself, rather than a separate ingredient in a formulation.
[Discovery account by Knudsen and Lau, 2019](https://pmc.ncbi.nlm.nih.gov/articles/PMC6474072/)
Who is this for
People seeking FDA-approved weight loss medication · Type 2 diabetics needing blood sugar control · Those who prefer daily dosing over weekly · Individuals starting GLP-1 therapy
Market evidence
Liraglutide product testing and COAs
We have not assessed certificate coverage for Liraglutide yet. Research on this page describes the molecule. Vendor certificates concern particular market samples or batches; they do not change the research evidence or establish clinical safety, sterility, or suitability for use.
Liraglutide research
The clinic network
Want a clinician's view on Liraglutide?
Request a free connection to a peptide clinic, by telehealth or in person. A licensed clinician decides whether any treatment is right for you. What peptide therapy involves
Related Peptides
Survodutide
THE DUAL ACTIONBGoodWeight Loss · Metabolic HealthMetabolic · Weight LossDoseSee guide↻CycleFollow the selected study protocol; do not...◷Kicks inSee guideNext-generation dual GLP-1/glucagon agonist for enhanced weight loss and metabolic benefits.
Full profileNº 005 / 006Adipotide
THE FAT BURNERCModerateWeight Loss · Fat LossMetabolic · Weight LossDoseSee guide↻CycleNo established SubQ dosing cycle.◷Kicks inSee guideTargets and destroys fat cells by cutting off their blood supply.
from $7.30/mg · 26 vendorsNº 001 / 006MOTS-c
THE METABOLIC MESSENGERBGoodMetabolic Modulator · Mitochondrial SupportMetabolic · Metabolic ModulatorDose5 mg↻Cycle8-12 weeks on, 4 weeks off◷Kicks inMetabolic improvements may be measurable...Exercise in a peptide. Boost metabolism without the treadmill
from $1.20/mg · 300 vendorsNº 003 / 006Selank
THE ANXIETY REDUCERAHighNootropic · Anxiety ManagementCognitive · NootropicDose400 mcg↻Cycle6 weeks on, 6 weeks off◷Kicks inAnti-anxiety effects often noticed within...Calms anxiety while improving focus and cognitive function for balanced mood.
from $1.80/mg · 204 vendorsNº 004 / 006BPC-157
THE HEALERAHighAccelerated Healing · Neurological SupportHealing · Accelerated HealingDose250 mcg↻Cycle4-8 weeks on, then equal break◷Kicks inRecovery improvements often noticed within...Accelerates healing of tendons, ligaments, gut, and muscles throughout your body.
from $1/mg · 320 vendorsNº 002 / 006Thymosin Alpha-1
THE IMMUNE SUPERCHARGERAHighAccelerated Healing · Anti-InflammatoryHealing · Accelerated HealingDose1 mg↻CycleNo clinically established cycle for this...◷Kicks inImmune enhancement often measurable within...Strengthens immunity by maturing T-cells, used for infections and cancer support
from $3.20/mg · 150 vendorsNº 006 / 006